Two chapters of the Scleroderma Foundation have events in October that may be of interest to Raynaud's sufferers: Scleroderma Foundation Delaware Valley Chapter is having a fundraiser walk in Philadelphia on October 14, 2012: http://is.gd/pyTYv3 Scleroderma Foundation / Tri-State Chapter is having a Product Fair on Saturday, October 13, 2012, 1:30 PM-3:30 PM in
Drug Intended for the Treatment of Raynaud's Phenomena, Secondary to Systemic Sclerosis SAN DIEGO, April 13, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today its filing with the U.S. Food & Drug Administration ("FDA") requesting orphan drug designation for RayVa™, the Company's drug candidate indicated for the treatment of Raynaud's
Modified-Release Therapy is Well Tolerated in Clinical Trial Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor